Assessing a New Tool to Assess Frailty in Frail Hospitalized Elderly
ConditionFrail Elderly Syndrome
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorUniversity of British Columbia
About this trial
The major purpose of this study is to establish the use of daily step counts as inexpensive, easy to measure marker for frailty and sarcopenia in an inpatient population of older adults.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
be 65 years of age or older
be admitted in ACE Unit
Disqualifiers
be less than 65 years of age
be nonambulatory
be diagnosed with end-stage organ failure (end-stage COPD, renal failure requiring dialysis, end-stage heart failure)
Trial population
Study population will be recruited consecutively from the Acute Care of the Elderly Unit at SPH.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
ActivPAL3 VT (PAL Technologies Ltd).
Device. The ActivPAL will be fitted by a trained research assistant on the mid-thigh of the participants' dominant leg. ActivPALs have an inclinometer that detects the joint angle of the thigh to capture lying, sitting, standing, and stepping activities.
Treatment groups
120 Participants
are divided into 1 treatment groupGroup A: Frail hospitalized old adults1 intervention
Trial outcomes
Primary outcomes
1
Total standing time
Total upright time will show a strong association with both continuous measures of frailty (Clinical Frailty Scale) and the presence of sarcopenia, as measured by ultrasound and bioelectric impedance measures.
Time frame
2 weeks or shorterSecondary outcomes
1
Daily step counts
2\. Daily step counts will show strong correlations with patient outcomes (length of stay, readmission rates, discharge to care facility, functional outcomes at 1year, and mortality rates).
Time frame
2 weeks or shorterSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov